Why now: campaign-01: capital deployment window 2026-09-08

What was noticed?

Delivered AI capacity and financial strain can coexist; a spending reckoning requires verified capex reductions and corroborating supplier deterioration.

Why might it matter?

The campaign verdict is INTACT, risk lens. The unresolved branch cannot be promoted from a price move or a historical model alone.

What evidence is real, and what is still only a pointer?

Receipt selector: CRWV-Q2-2026 in the campaign thesis review and its accompanying receipts.

Still required: Hyperscaler spending guide-downs, supplier cancellations and deteriorating software economics.

Which existing research does it update or duplicate?

The registered ai-capex-digestion perspective. This question tracks the unresolved branch of the campaign review, not a duplicate completed finding.

What should be written if the evidence clears?

A sourced perspective update adjudicating this exact test: Verified hyperscaler guide-down together with supplier deterioration escalates risk; spending and software repair weaken it.

Reviewed September 6 using September 4 settled prices. September 7 is the U.S. Labor Day holiday; the decision window is September 8.